Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Geriatric Communication Skills Training Program for Oncology Clinicians

Not Applicable

Completed

Conditions: Lymphoma
Bone Marrow Transplant
GU Cancer
GI Cancer

Interventions: Behavioral: The Consultation and Relational Empathy (CARE) questionnaire
Behavioral: Self-Efficacy Assessment
Behavioral: Consumer Assessment of Health Care Providers and Systems Program (CAHPS)
Behavioral: UCLA Geriatrics Attitudes Scale
Behavioral: Course Evaluations
Behavioral: Patient activation measure (PAM) scale

First Posted Date: 2018-05-21

Last Posted Date: 2024-02-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 88

Registration Number: NCT03530969

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer

Phase 2

Active, not recruiting

Conditions: Pancreatic Cancer

Interventions: Radiation: Hypofractionated ablative IMRT (HFA-IMRT)
Drug: capecitabine

First Posted Date: 2018-05-14

Last Posted Date: 2025-05-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 47

Registration Number: NCT03523312

Locations: 🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 5 locations

Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

Phase 1

Completed

Conditions: Cutaneous Squamous Cell Carcinoma
Head and Neck Cancer
Head and Neck Carcinoma
Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Lenvatinib Pill
Drug: Cetuximab

First Posted Date: 2018-05-14

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT03524326

Locations: 🇺🇸
Memoral Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memoral Sloan Kettering Westchester, Harrison, New York, United States

and more 4 locations

Overnight Fasting After Completion of Therapy: The OnFACT Study

Not Applicable

Recruiting

Conditions: Childhood Cancer Survivors

Interventions: Other: usual care
Other: prolonged overnight fasting

First Posted Date: 2018-05-14

Last Posted Date: 2024-08-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT03523377

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain

Phase 1

Completed

Conditions: Metastatic Solid Tumors of Metastatic Disease

Interventions: Radiation: Radiation Therapy
Drug: Systemic Therapy

First Posted Date: 2018-05-14

Last Posted Date: 2025-04-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 78

Registration Number: NCT03523351

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 6 locations

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

Phase 2

Recruiting

Conditions: Bladder Cancer

Interventions: Drug: Nivolumab
Drug: Ipilimumab
Procedure: Radical cystectomy

First Posted Date: 2018-05-09

Last Posted Date: 2025-04-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 45

Registration Number: NCT03520491

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases

Phase 1

Completed

Conditions: Leptomeningeal Metastases

Interventions: Radiation: Proton craniospinal irradiation (CSI)

First Posted Date: 2018-05-09

Last Posted Date: 2022-12-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT03520504

Locations: 🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 5 locations

Pilot Trial of the Robotic Uterine Manipulator

Not Applicable

Completed

Conditions: Gynecologic Surgery

Interventions: Device: BAUM device

First Posted Date: 2018-05-07

Last Posted Date: 2024-08-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT03517228

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent only), Harrison, New York, United States

and more 4 locations

Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation

Not Applicable

Completed

Conditions: Multiple Myeloma

Interventions: Diagnostic Test: Structural Image
Diagnostic Test: Functional Image
Behavioral: Digit Span subtest
Behavioral: Brief Test of Attention
Behavioral: Trail Making Test (Parts A & B)
Behavioral: Auditory Consonant Trigrams Test
Behavioral: Controlled Oral Word Association Test
Behavioral: Hopkins Verbal Learning Test-Revised
Behavioral: The Center for Epidemiological Study-Depression
Behavioral: The Functional Assessment of Chronic Illness Therapy-Fatigue Subscale, Version 4
Other: Blood draw

First Posted Date: 2018-04-26

Last Posted Date: 2024-03-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT03508765

Locations: 🇺🇸
Rutgers University - Data Analysis, New Brunswick, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Early Staged Consent Before Prostate Biopsy

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: Meditation
Procedure: Prostate Biopsy
Behavioral: Questionnaires

First Posted Date: 2018-04-25

Last Posted Date: 2024-10-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 390

Registration Number: NCT03507725

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

AI-Powered Research

Premium Access

Memorial Sloan Kettering Cancer Center

Geriatric Communication Skills Training Program for Oncology Clinicians

Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer

Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

Overnight Fasting After Completion of Therapy: The OnFACT Study

Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases

Pilot Trial of the Robotic Uterine Manipulator

Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation

Early Staged Consent Before Prostate Biopsy